Akoya BioSciences
AKYA
AKYA was delisted on the 7th of July, 2025.
64 hedge funds and large institutions have $32.8M invested in Akoya BioSciences in 2025 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 19 reducing their positions, and 7 closing their positions.
7,400% more call options, than puts
Call options by funds: $75K | Put options by funds: $1K
43% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 7
18% more capital invested
Capital invested by funds: $27.8M → $32.8M (+$5.05M)
5% more funds holding
Funds holding: 61 → 64 (+3)
0.75% more ownership
Funds ownership: 24.49% → 25.24% (+0.75%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$795K |
| 2 |
Nuveen
Charlotte,
North Carolina
|
+$771K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$431K |
| 4 |
CIEC
Crédit Industriel et Commercial
Paris France,
France
|
+$372K |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
+$364K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SW
SVB Wealth
Boston,
Massachusetts
|
-$1.13M |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$414K |
| 3 |
OCM
Osterweis Capital Management
San Francisco,
California
|
-$289K |
| 4 |
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture
Dallas,
Texas
|
-$285K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$279K |
AKYA Hedge Fund Activity: Q1 2025 in Review
64 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Akoya BioSciences (AKYA) for Q1 2025, worth a combined $32.8M — up 18% from $27.8M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new AKYA positions and 7 closed out — a net gain of 3 holders — while 19 added to existing stakes and 19 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $795K. The largest seller was SVB Wealth, cutting an estimated $1.13M.
- 64 institutional investors held Akoya BioSciences (AKYA) as of Q1 2025, up from 61 in Q4 2024.
- Funds reported $32.8M of Akoya BioSciences stock for Q1 2025, up 18% quarter-over-quarter.
- 10 funds opened new Akoya BioSciences positions in Q1 2025 and 7 closed out, a net change of +3 holders.
- The largest Akoya BioSciences buyer in Q1 2025 was JP Morgan Chase, an estimated $795K added.
- The largest Akoya BioSciences seller in Q1 2025 was SVB Wealth, an estimated $1.13M sold.
Based on aggregated 13F filings for Q1 2025.